openPR Logo
Press release

Malaria Vaccines Market Growth Analysis 2026 By Top Key Players - GlaxoSmithKline, GenVec, Inc., Nobelpharma, and Sanaria. Some other promising vendors are Cadila Healthcare Ltd., CellFree Sciences Co. Ltd., VLP Therapeutics LLC, and Genome ReS Ltd

04-28-2020 06:38 AM CET | Health & Medicine

Press release from: marketstudyreport.com

/ PR Agency: marketstudyreport
Malaria Vaccines Market Growth Analysis 2026 By Top Key Players -

The Malaria Vaccines Market analytical summative by Market Study Report, LLC, is a thorough study on the latest market trends prevailing in the global business sphere. The report also offers important details pertaining to market share, market size, profit estimations, applications and statistics of this industry. The report further presents a detailed competitive analysis including growth strategies adopted by key players of the industry.

The malaria vaccines market is expected to reach USD 156.8 million by 2026 according to a new study.The market for malaria vaccines globally has been divided based on vaccine type, agent, channel of distribution and region. Considering the vaccine type, the market is bifurcated into pre-erythrocytic vaccine, erythrocytic vaccine, and multi-antigen vaccine.

Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/1695270?utm_source=Openpr.com&utm_medium=AN

The leading players operating in the malaria vaccines market globally are GlaxoSmithKline, GenVec, Inc., Nobelpharma, and Sanaria. Some other promising vendors are Cadila Healthcare Ltd., CellFree Sciences Co. Ltd., VLP Therapeutics LLC, and Genome ReS Ltd. among others.

The channel of distribution used for malaria vaccines include the hospitals, clinics and community centers. Considering the agent used in the malaria vaccines, the global market is divided into plasmodium falciparum, anopheles species, and plasmodium vivax. Geographically, the Asia Pacific region is expected to grow at the fastest rate among all the other regions with Middle-east & Africa and Latin America likely to be the other potential regions for malaria vaccines market. North America and Europe have considerable lower cases of malaria related diseases with regions such as Latin America and MEA monitoring some of the highest deaths of children related to malaria globally.

A few key factors boosting the malaria vaccines market are the growing incidences of malaria along with the presence of numerous companies that are introducing low profit margin vaccines across the world. Moreover, rising awareness related to the aftermaths of the disease, together with growing diagnosis and higher treatment rate are a few other driving factors boosting the malaria vaccines market globally.

However, it is high price of vaccines, and weaker supply chain or distribution network in the developing countries among others that act as some of the major restraints for the market growth of malaria vaccines globally. It is expected that the ongoing research activities along with alarming death rates by malaria will further provide numerous opportunities for the growth of the malaria vaccines market in the upcoming years.

A few key strategies adopted by companies operating in the malaria vaccines market are new technology and product development, and geographical expansion among the developing regions to focus on proving vaccines to the areas highly affected by the disease at lower cost. World Health Organization (WHO), in 2015, around 292,000 children died of malaria, at the young age of 5 years in Africa. There were around 306,000 fatalities associated with malaria that was reported worldwide in 2015, out of which around 90% cases were found in Africa. This scenario shows the rising need for empathy towards the disease as well as higher demand for low cost vaccinations.

Purchase full report of Malaria Vaccines Market at: https://www.marketstudyreport.com/securecheckout/paymenta/1695270?msfpaycode=sumst?utm_source=Openpr.com&utm_medium=AN

Table of Contents

1. Overview and Scope
2. Executive Summary
3. Malaria Vaccines Market Insights
4. Malaria Vaccines Market Size and Forecast by Agent
5. Malaria Vaccines Market Size and Forecast by Vaccines Type
6. Malaria Vaccines Market Size and Forecast by Channel of Distribution
7. Malaria Vaccines Market Size and Forecast by Regions

buying decision on this premium report https://www.marketstudyreport.com/enquiry-before-buying/1695270?utm_source=Openpr.com&utm_medium=AN

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Malaria Vaccines Market Growth Analysis 2026 By Top Key Players - GlaxoSmithKline, GenVec, Inc., Nobelpharma, and Sanaria. Some other promising vendors are Cadila Healthcare Ltd., CellFree Sciences Co. Ltd., VLP Therapeutics LLC, and Genome ReS Ltd here

News-ID: 2026674 • Views: 288

More Releases from marketstudyreport.com

Covid -19 Impact on Video Conferencing Market Size 2026: Top Companies, Trends a …
Market Study Report recently introduced new title on “2020-2026 Global Video Conferencing Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates Market size outlook and status to 2026. Video Conferencing Market size is anticipated to grow at over 19% CAGR between 2020 and 2026. The global video conferencing market is set to register a tremendous rise in its growth
What's driving the Patient Monitoring Devices Market Size? Fukuda, Philips, Skan …
Selbyville, Delaware the prime objective of Patient Monitoring Devices report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. Wireless segment is anticipated to witness more than 5% growth over the forecast period. Substantial growth can be attributed to rising preference for
What's driving the 3D Implants Market trends? Stryker, Smith and Nephew, DJO Glo …
The 3D Implants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Request a sample Report of 3D Implants Market at: https://www.marketstudyreport.com/request-a-sample/2679238/?utm_source=OPR.com/&utm_medium=SP The most likely (base case) scenario
Artificial Vascular Implants Market is thriving worldwide by 2025 | Top Key Play …
Global Artificial Vascular Implants Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Artificial Vascular Implants Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Artificial Vascular Implants market and provides information regarding the revenue for the period 2020 to 2025. The Artificial Vascular Implants market report provides

All 5 Releases


More Releases for Vaccines

Global Influenza Vaccines Market
Global Influenza Vaccines Market Size, Share, Analysis, Growth, Trends, and Forecast to 2027 Worldwide Influenza Vaccines Market size is expected to exceed USD 7.5 billion by 2027. The report contains a deep analysis of the worldwide influenza vaccines market with size in terms of both value and volume. The report provides a clear insight into current and future developments of the worldwide influenza vaccines market. The report also explores a detailed analysis
Designing multi-purpose vaccines
Scientists from the five year EU funded project MycoSynVac report their findings and successes at a final meeting in Brussels. The project drew on cutting edge biotechnology to explore three important GOALS: 1. TRANSFORM a living bacteria (Mycoplasma pneumoniae) into a vaccine chassis 2. APPLY this vaccine chassis against bacterial diseases in livestock animals, 3. CONTRIBUTE to the reduction of antibiotics administered to farm animals A well-rounded approach to science featuring
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Global Veterinary Vaccines Market
The Global Veterinary Vaccines Market was valued at US$ 5,688.7 million in 2015 and is projected to expand at a CAGR of 5.9% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Rise in incidence of food-borne zoonotic diseases along with increase in population of livestock is expected to favor growth of the veterinary vaccines market. According to European food safety authority (EFSA),